Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 11 results.
User Information
Export Records
  1. 1.   Enhanced Control of Pathogenic Simian Immunodeficiency Virus SIVmac239 Replication in Macaques Immunized with an Interleukin-12 Plasmid and a DNA Prime-Viral Vector Boost Vaccine Regimen
  2. Winstone, N.; Wilson, A. J.; Morrow, G.; Boggiano, C.; Chiuchiolo, M. J.; Lopez, M.; Kemelman, M.; Ginsberg, A. A.; Mullen, K.; Coleman, J. W.; Wu, C. D.; Narpala, S.; Ouellette, I.; Dean, H. J.; Lin, F.; Sardesai, N. Y.; Cassamasa, H.; McBride, D.; Felber, B. K.; Pavlakis, G. N.; Schultz, A.; Hudgens, M. G.; King, C. R.; Zamb, T. J.; Parks, C. L.; McDermott, A. B.
  3. Journal of Virology. 2011, Sep; 85(18): 9578-9587.
  1. 2.   Mechanisms of Human Immunodeficiency Virus Type 2 RNA Packaging: Efficient trans Packaging and Selection of RNA Copackaging Partners
  2. Ni, N.; Nikolaitchik, O. A.; Dilley, K. A.; Chen, J. B.; Galli, A.; Fu, W.; Prasad, V.; Ptak, R. G.; Pathak, V. K.; Hu, W. S.
  3. Journal of Virology. 2011, Aug; 85(15): 7603-7612.
  1. 3.   Partial protection against SIV challenge by vaccination of adenovirus and MVA vectors in rhesus monkeys
  2. Wang, H. B.; Kondo, A.; Yoshida, A.; Yoshizaki, S.; Abe, S.; Bao, L. L.; Mizuki, N.; Ichino, M.; Klinman, D.; Okuda, K.; Shimada, M.
  3. Gene Therapy. 2010, Jan; 17(1): 4-13.
  1. 4.   Adenovirus type 5 with modified hexons induces robust transgene-specific immune responses in mice with pre-existing immunity against adenovirus type 5
  2. Abe, S.; Okuda, K.; Ura, T.; Kondo, A.; Yoshida, A.; Yoshizaki, S.; Mizuguchi, H.; Klinman, D.; Shimada, M.
  3. Journal of Gene Medicine. 2009 11(7): 570-579.
  1. 5.   Effect of therapeutic immunization using Ad5/35 and MVA vectors on SIV infection of rhesus monkeys undergoing antiretroviral therapy
  2. Shimada, M.; Wang, H. B.; Kondo, A.; Xu, X. P.; Yoshida, A.; Shinoda, K.; Ura, T.; Mizuguchi, H.; Klinman, D.; Luo, J. L.; Bai, H.
  3. Gene Therapy. 2009 16(2): 218-228.
  1. 6.   Filovirus-like particles produced in insect cells: Immunogenicity and protection in rodents
  2. Warfield, K. L.; Posten, N. A.; Swenson, D. L.; Olinger, G. G.; Esposito, D.; Gillette, W. K.; Hopkins, R. F.; Costantino, J.; Panchal, R. G.; Hartley, J. L.; Aman, M. J.; Bavari, S.
  3. Journal of Infectious Diseases. 2007, Nov; 196: S421-S429.
  1. 7.   Multiagent vaccines vectored by Venezuelan equine encephalitis virus replicon elicits immune responses to Marburg virus and protection against anthrax and botulinum neurotoxin in mice
  2. Lee, J. S.; Groebner, J. L.; Hadjipanayis, A. G.; Negley, D. L.; Schmaljohn, A. L.; Welkos, S. L.; Smith, L. A.; Smith, J. F.
  3. Vaccine. 2006, Nov; 24(47-48): 6886-6892.
  1. 8.   Oral delivery of replication-competent adenovirus vectors is well tolerated by SIV- and SHIV-infected rhesus macaques
  2. Gomez-Roman, V. R.; Grimes, G. J.; Potti, G. K.; Peng, B.; Demberg, T.; Gravlin, L.; Treece, J.; Pal, R.; Lee, E. M.; Alvord, W. G.; Markham, P. D.; Robert-Guroff, M.
  3. Vaccine. 2006, Jun; 24(23): 5064-5072.
  1. 9.   Effect of posttranscriptional regulatory elements on transgene expression and virus production in the context of retrovirus vectors
  2. Hlavaty, J.; Schittmayer, M.; Stracke, A.; Jandl, G.; Knapp, E.; Felber, B. K.; Salmons, B.; Gunzburg, W. H.; Renner, M.
  3. Virology. 2005, OCT 10; 341(1): 1-11.
  1. 10.   Sustained hepatic and renal glucose-6-phosphatase expression corrects glycogen storage disease type Ia in mice
  2. Sun, M. S.; Pan, C. J.; Shieh, J. J.; Ghosh, A.; Chen, L. Y.; Mansfield, B. C.; Ward, J. M.; Byrne, B. J.; Chou, J. Y.
  3. Human Molecular Genetics. 2002 11(18): 2155-2164.
  1. 11.   Association of specific DNA binding and transcriptional repression with the transforming and myogenic activities of c-Ski
  2. Nicol, R.; Zheng, G.; Sutrave, P.; Foster, D. N.; Stavnezer, E.
  3. Cell Growth and Differentiation. 1999 10(4): 243-254.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel